Endocrine function after bone marrow transplantation for thalassemia.
Galimberti
M
M
Divisione di Ematologia, Ospedale di Pesaro, Italy.
De Sanctis
V
V
Lucarelli
G
G
Polchi
P
P
Angelucci
E
E
Baronciani
D
D
Vullo
C
C
Bagni
B
B
D000293:Adolescent; D016026:Bone Marrow Transplantation / Q000009:adverse effects* / Q000379:methods / Q000502:physiology; D002066:Busulfan / Q000009:adverse effects*; D002648:Child; D003520:Cyclophosphamide / Q000009:adverse effects*; D004700:Endocrine System Diseases / Q000139:chemically induced*; D005260:Female; D006801:Humans; D008297:Male; D011184:Postoperative Period; D011628:Puberty, Delayed / Q000139:chemically induced; D011788:Quality of Life; D013789:Thalassemia / Q000503:physiopathology / Q000601:surgery*
D003520:Cyclophosphamide; D002066:Busulfan